Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

10 Nov 2022 09:42

RNS Number : 9939F
Mandarin Oriental International Ltd
10 November 2022
Β 

Announcement

Β 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

Β 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

Β 

10th November 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2022.

Β 

The return of normal travel conditions in most of the world in early 2022 saw the Group record net underlying profits (unaudited) in the second quarter, and this progress continued in the third quarter.

Β 

In the Group's owned hotels, improvements in occupancy and high rates resulted in a stronger performance in the third quarter. This drove increased profitability compared to the second quarter, particularly in Paris and Munich. Two of the Group's key profit-generating hotels, in Hong Kong and Tokyo, however, remained subject to stringent travel restrictions throughout the third quarter, which significantly impacted operating performance. The hotels in Bangkok and Singapore continued their recovery following the removal of travel barriers.

Β 

The performance of the management business was strong in the third quarter and it recorded a significant improvement in profitability compared to the second quarter. Of particular note were the contributions made by a number of the Group's Mediterranean and Middle Eastern properties.

Β 

As a result of the improved trading conditions and Mandarin Oriental's expanded portfolio of hotels and residences, the Group recorded its highest quarterly EBITDA since 2019. Both the owned hotels and the management business delivered higher EBITDA than in the second quarter of 2022.

Β 

In September 2022, the Group opened Mandarin Oriental Palace, Luzern, its second hotel in Switzerland, and its standalone residences project in Barcelona. Recently, the Group announced a new hotel in Tianfu, the new business district of Chengdu, further expanding its presence in China. On 8th September 2022, the Group completed the sale of Mandarin Oriental, Washington D.C., for US$139 million. As a result, the Group has recognised a post-tax, non-trading gain in the third quarter of US$47 million.

Β 

Following the disposal, net debt at 30th September 2022 reduced to US$385 million (US$519 million at 30th June 2022), and the Group held US$267 million of cash reserves and US$472 million in available, committed debt facilities. Gearing was 8% of adjusted shareholders' funds.

Β 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

Β 

- end -

Β 

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

Β 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DOCKBLBFLFLXFBK
Date   Source Headline
29th Jul 202010:53 amRNSFirst Half 2020 Results of PT Hero
29th Jul 202010:44 amRNSPT Astra International Tbk - First Half Results
30th Jun 202010:33 amRNSTotal Voting Rights
30th Jun 202010:25 amRNSExtractive Sector: Payments to Govts Report 2019
23rd Jun 202011:08 amRNSTransaction in Own Shares
22nd Jun 202011:30 amRNSTransaction in Own Shares
19th Jun 202012:12 pmRNSTransaction in Own Shares
18th Jun 202011:43 amRNSTransaction in Own Shares
18th Jun 202010:29 amRNSDirector/PDMR Shareholding
18th Jun 20207:00 amRNSTransaction in Own Shares
15th Jun 202011:21 amRNSTransaction in Own Shares
15th Jun 202010:21 amRNSDirector Declaration
12th Jun 202011:53 amRNSTransaction in Own Shares
11th Jun 202011:46 amRNSTransaction in Own Shares
10th Jun 202010:27 amRNSFist Quarter 2020 Results of PT Hero
5th Jun 202011:10 amRNSTransaction in Own Shares
2nd Jun 202012:35 pmRNSDirector/PDMR Shareholding
29th May 202010:31 amRNSTotal Voting Rights
26th May 202011:43 amRNSTransaction in Own Shares
21st May 202010:27 amRNSDirector/PDMR Shareholding
19th May 202010:20 amRNSDirector/PDMR Shareholding
13th May 202010:53 amRNSDirector/PDMR Shareholding
12th May 202010:21 amRNSDirector/PDMR Shareholding
11th May 202010:23 amRNSAdditional Listing
7th May 202012:13 pmRNSAGM Statement
7th May 202012:13 pmRNSResult of AGM
29th Apr 202010:20 amRNSDividend
28th Apr 202010:38 amRNSInterim Management Statement
28th Apr 202010:37 amRNSInterim Management Statement
28th Apr 202010:28 amRNSInterim Management Statement
28th Apr 202010:20 amRNSInterim Management Statement
27th Apr 202010:55 amRNSJC&C Interim Management Statements
27th Apr 202010:47 amRNSPT ASTRA 2020 FIRST QUARTER FINANCIAL STATEMENTS
27th Apr 202010:33 amRNSDisclosure of Rights Attached to Ordinary Shares
24th Apr 202011:44 amRNSDividend
9th Apr 202010:21 amRNSInterim Management Statement
7th Apr 202010:20 amRNSAnnual Financial Report
1st Apr 202010:20 amRNSCirc re. Scrip Dividend Scheme
31st Mar 202010:20 amRNSTotal Voting Rights
30th Mar 202010:56 amRNSDirector Declaration
25th Mar 20209:22 amRNSBlock listing Interim Review
20th Mar 20209:27 amRNSDirector Declaration
20th Mar 20209:25 amRNSDirector/PDMR Shareholding
13th Mar 20209:22 amRNSShare Purchase
5th Mar 202012:08 pmRNSFinal Results
5th Mar 202012:07 pmRNSFinal Results
5th Mar 202010:03 amRNSFinal Results Mandarin Oriental International Ltd
5th Mar 202010:01 amRNSDirectorate Change
5th Mar 20209:58 amRNSFinal Results
5th Mar 20209:53 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.